{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T16:32:02Z","timestamp":1786120322945,"version":"build-2736575974"},"reference-count":38,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2011,8]]},"DOI":"10.1097\/mph.0b013e3182260cbe","type":"journal-article","created":{"date-parts":[[2011,7,26]],"date-time":"2011-07-26T04:21:40Z","timestamp":1311654100000},"page":"442-449","source":"Crossref","is-referenced-by-count":20,"title":["Duration of Adrenal Insufficiency During Treatment for Childhood Acute Lymphoblastic Leukemia"],"prefix":"10.1097","volume":"33","author":[{"given":"Therese Risom","family":"Vestergaard","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anders","family":"Juul","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ulrik","family":"Lausten-Thomsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Birgitte","family":"Lausen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Henrik","family":"Hjalgrim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tine Kajsa","family":"Kvist","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisabeth Wreford","family":"Andersen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kjeld","family":"Schmiegelow","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-10-20210227","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1056\/NEJM197607012950107","article-title":"Withdrawal from glucocorticoid therapy.","volume":"295","author":"Byyny","year":"1976","journal-title":"N Engl J Med"},{"key":"R3-10-20210227","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1542\/peds.2006-1612","article-title":"Adrenal insufficiency: still a cause of morbidity and death in childhood.","volume":"119","author":"Shulman","year":"2007","journal-title":"Pediatrics"},{"key":"R5-10-20210227","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/00043426-199502000-00001","article-title":"The use of glucocorticoids in acute lymphoblastic leukemia of childhood. Molecular, cellular, and clinical considerations.","volume":"17","author":"Gaynon","year":"1995","journal-title":"J Pediatr Hematol Oncol"},{"key":"R6-10-20210227","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1038\/leu.2009.303","article-title":"The degree of myelosuppression during maintenance therapy of adolescents with B-lineage intermediate risk acute lymphoblastic leukemia predicts risk of relapse.","volume":"24","author":"Schmiegelow","year":"2010","journal-title":"Leukemia"},{"key":"R7-10-20210227","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1136\/adc.74.2.101","article-title":"Treatment related deaths during induction and in first remission in acute lymphoblastic leukaemia: MRC UKALL X.","volume":"74","author":"Wheeler","year":"1996","journal-title":"Arch Dis Child"},{"key":"R8-10-20210227","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1111\/j.1365-2141.2005.05736.x","article-title":"Treatment-related death in childhood acute lymphoblastic leukaemia in the Nordic countries: 1992 to 2001.","volume":"131","author":"Christensen","year":"2005","journal-title":"Br J Haematol"},{"key":"R9-10-20210227","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1111\/j.1600-0609.2006.00632.x","article-title":"Infections during induction therapy of childhood acute lymphoblastic leukaemiano association to mannose-binding lectin deficiency.","volume":"76","author":"Lausen","year":"2006","journal-title":"Eur J Haematol"},{"key":"R10-10-20210227","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/0021-9681(73)90030-1","article-title":"The clinical significance of pituitary-adrenal suppression by exogenous corticosteroids.","volume":"26","author":"Christy","year":"1973","journal-title":"J Chronic Dis"},{"key":"R11-10-20210227","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1016\/S0140-6736(79)91077-8","article-title":"Adrenal suppression after short-term corticosteroid therapy.","volume":"1","author":"Spiegel","year":"1979","journal-title":"Lancet"},{"key":"R12-10-20210227","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1016\/j.jpeds.2005.06.006","article-title":"Clinical impact of corticosteroid-induced adrenal suppression during treatment for acute lymphoblastic leukemia in children: a prospective observational study using the low-dose adrenocorticotropin test.","volume":"147","author":"Rix","year":"2005","journal-title":"J Pediatr"},{"key":"R13-10-20210227","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1067\/mpd.2000.107385","article-title":"Time course of recovery of adrenal function in children treated for leukemia.","volume":"137","author":"Felner","year":"2000","journal-title":"J Pediatr"},{"key":"R14-10-20210227","first-page":"790","article-title":"Rapid adrenocortical recovery after short-term glucocorticoid therapy.","volume":"135","author":"Lightner","year":"1981","journal-title":"Am J Dis Child"},{"key":"R15-10-20210227","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1016\/S0022-3476(04)00233-1","article-title":"Suppression of adrenal function in children with acute lymphoblastic leukemia following induction therapy with corticosteroid and other cytotoxic agents.","volume":"144","author":"Mahachoklertwattana","year":"2004","journal-title":"J Pediatr"},{"key":"R16-10-20210227","doi-asserted-by":"crossref","first-page":"2993","DOI":"10.1210\/jcem.86.7.7629","article-title":"Evaluation of the hypothalamic-pituitary-adrenal axis in children with leukemia before and after 6 weeks of high-dose glucocorticoid therapy.","volume":"86","author":"Kuperman","year":"2001","journal-title":"J Clin Endocrinol Metab"},{"key":"R17-10-20210227","doi-asserted-by":"crossref","first-page":"2797","DOI":"10.1210\/jc.2003-031165","article-title":"Early adrenocortical recovery after glucocorticoid therapy in children with leukemia.","volume":"89","author":"Cunha","year":"2004","journal-title":"J Clin Endocrinol Metab"},{"key":"R18-10-20210227","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1097\/01.mph.0000155870.38794.e7","article-title":"Steroid withdrawal syndrome during steroid tapering in childhood acute lymphoblastic leukemia: a controlled study comparing prednisone versus dexamethasone in induction phase.","volume":"27","author":"Saracco","year":"2005","journal-title":"J Pediatr Hematol Oncol"},{"key":"R19-10-20210227","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1002\/mpo.10316","article-title":"Impaired adrenal function after glucocorticoid therapy in children with acute lymphoblastic leukemia.","volume":"41","author":"Petersen","year":"2003","journal-title":"Med Pediatr Oncol"},{"key":"R20-10-20210227","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1002\/pbc.21339","article-title":"Adrenal axis function after high-dose steroid therapy for childhood acute lymphoblastic leukemia.","volume":"50","author":"Einaudi","year":"2008","journal-title":"Pediatr Blood Cancer"},{"key":"R22-10-20210227","doi-asserted-by":"crossref","first-page":"61","DOI":"10.2165\/00003088-200544010-00003","article-title":"Pharmacokinetics and pharmacodynamics of systemically administered glucocorticoids.","volume":"44","author":"Czock","year":"2005","journal-title":"Clin Pharmacokinet"},{"key":"R23-10-20210227","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1111\/j.1749-6632.2000.tb05371.x","article-title":"The stress response and immune function: clinical implications. The 1999 Novera H. Spector Lecture.","volume":"917","author":"Chrousos","year":"2000","journal-title":"Ann N Y Acad Sci"},{"key":"R24-10-20210227","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1097\/01.PCC.0000262796.38637.15","article-title":"Identification of adrenal insufficiency in pediatric critical illness.","volume":"8","author":"Menon","year":"2007","journal-title":"Pediatr Crit Care Med"},{"key":"R25-10-20210227","doi-asserted-by":"crossref","first-page":"1326","DOI":"10.1210\/jc.2006-1791","article-title":"Factors influencing the adrenocorticotropin test: role of contemporary cortisol assays, body composition, and oral contraceptive agents.","volume":"92","author":"Klose","year":"2007","journal-title":"J Clin Endocrinol Metab"},{"key":"R27-10-20210227","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1038\/leu.2009.251","article-title":"Long-term results of NOPHO ALL-92 and ALL-2000 studies of childhood acute lymphoblastic leukemia.","volume":"24","author":"Schmiegelow","year":"2010","journal-title":"Leukemia"},{"key":"R28-10-20210227","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1111\/j.1399-3038.2007.00539.x","article-title":"Hypothalamic-pituitary-adrenal axis suppression in asthmatic children on inhaled corticosteroids (Part 2)the risk as determined by gold standard adrenal function tests: a systematic review.","volume":"18","author":"Zollner","year":"2007","journal-title":"Pediatr Allergy Immunol"},{"key":"R29-10-20210227","first-page":"923","article-title":"Clinical review 62: laboratory assessment of adrenal insufficiency.","volume":"79","author":"Grinspoon","year":"1994","journal-title":"J Clin Endocrinol Metab"},{"key":"R30-10-20210227","first-page":"191","article-title":"Significance of low-dose and standard-dose ACTH tests compared to overnight metyrapone test in the diagnosis of adrenal insufficiency in childhood.","volume":"60","author":"Gonc","year":"2003","journal-title":"Horm Res"},{"key":"R31-10-20210227","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1136\/adc.80.4.330","article-title":"Tests of adrenal insufficiency.","volume":"80","author":"Agwu","year":"1999","journal-title":"Arch Dis Child"},{"key":"R33-10-20210227","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1136\/bmj.298.6669.271","article-title":"Diagnosis of adrenal insufficiency.","volume":"298","author":"Clayton","year":"1989","journal-title":"BMJ"},{"key":"R34-10-20210227","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1136\/bmj.304.6820.173","article-title":"Hazards of pharmacological tests of growth hormone secretion in childhood.","volume":"304","author":"Shah","year":"1992","journal-title":"BMJ"},{"key":"R35-10-20210227","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1159\/000048932","article-title":"Changes in serum cortisol with age in critically ill patients.","volume":"48","author":"Beale","year":"2002","journal-title":"Gerontology"},{"key":"R36-10-20210227","first-page":"838","article-title":"Comparison of the low dose short synacthen test (1 microg), the conventional dose short synacthen test (250 microg), and the insulin tolerance test for assessment of the hypothalamo-pituitary-adrenal axis in patients with pituitary disease.","volume":"84","author":"Abdu","year":"1999","journal-title":"J Clin Endocrinol Metab"},{"key":"R37-10-20210227","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1046\/j.1365-2265.2000.01028.x","article-title":"Establishment of reference values for standard dose short synacthen test (250 microgram), low dose short synacthen test (1 microgram) and insulin tolerance test for assessment of the hypothalamo-pituitary-adrenal axis in normal subjects.","volume":"53","author":"Gonzalbez","year":"2000","journal-title":"Clin Endocrinol (Oxf)"},{"key":"R38-10-20210227","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1210\/jcem.83.1.4496","article-title":"Standard and low-dose short adrenocorticotropin test compared with insulin-induced hypoglycemia for assessment of the hypothalamic-pituitary-adrenal axis in children with idiopathic multiple pituitary hormone deficiencies.","volume":"83","author":"Weintrob","year":"1998","journal-title":"J Clin Endocrinol Metab"},{"key":"R39-10-20210227","doi-asserted-by":"crossref","first-page":"4477","DOI":"10.1182\/blood-2007-09-112920","article-title":"Risk-adjusted therapy of acute lymphoblastic leukemia can decrease treatment burden and improve survival: treatment results of 2169 unselected pediatric and adolescent patients enrolled in the trial ALL-BFM 95.","volume":"111","author":"Moricke","year":"2008","journal-title":"Blood"},{"key":"R40-10-20210227","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1007\/978-1-4615-4811-9_66","article-title":"Glucocorticosteroid therapy in childhood acute lymphoblastic leukemia.","volume":"457","author":"Gaynon","year":"1999","journal-title":"Adv Exp Med Biol"},{"key":"R41-10-20210227","doi-asserted-by":"crossref","first-page":"4178","DOI":"10.1182\/blood-2008-06-165027","article-title":"Genome-wide copy number profiling reveals molecular evolution from diagnosis to relapse in childhood acute lymphoblastic leukemia.","volume":"112","author":"Yang","year":"2008","journal-title":"Blood"},{"key":"R42-10-20210227","doi-asserted-by":"crossref","first-page":"2137","DOI":"10.1038\/leu.2008.212","article-title":"Etiology of common childhood acute lymphoblastic leukemia: the adrenal hypothesis.","volume":"22","author":"Schmiegelow","year":"2008","journal-title":"Leukemia"},{"key":"R43-10-20210227","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/S0959-8049(98)00433-X","article-title":"Molecular genetics, natural history and the demise of childhood leukaemia.","volume":"35","author":"Greaves","year":"1999","journal-title":"Eur J Cancer"}],"container-title":["Journal of Pediatric Hematology\/Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/MPH.0b013e3182260cbe","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T20:21:35Z","timestamp":1786047695000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00043426-201108000-00010"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,8]]},"references-count":38,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2011]]}},"URL":"https:\/\/doi.org\/10.1097\/mph.0b013e3182260cbe","relation":{},"ISSN":["1077-4114"],"issn-type":[{"value":"1077-4114","type":"print"}],"subject":[],"published":{"date-parts":[[2011,8]]}}}